325 related articles for article (PubMed ID: 34098455)
1. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
[TBL] [Abstract][Full Text] [Related]
2. Different medications for the treatment of Ménière's disease by intratympanic injection: A systematic review and network meta-analysis.
Cao Z; Yue F; Huang W; Rajenderkumar D; Zhao F
Clin Otolaryngol; 2019 Jul; 44(4):619-627. PubMed ID: 31025490
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
Öztürk K; Ata N
Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
5. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
Gabra N; Saliba I
Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159
[TBL] [Abstract][Full Text] [Related]
6. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
7. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
Weckel A; Marx M; Esteve-Fraysse MJ
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM
Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease.
Harcourt JP; Lambert A; Wong PY; Patel M; Agarwal K; Golding JF; Bronstein AM
Otol Neurotol; 2019 Apr; 40(4):491-496. PubMed ID: 30870364
[TBL] [Abstract][Full Text] [Related]
10. Effects of intratympanic gentamicin and intratympanic glucocorticoids in Ménière's disease: a network meta-analysis.
Hao W; Yu H; Li H
J Neurol; 2022 Jan; 269(1):72-86. PubMed ID: 33387016
[TBL] [Abstract][Full Text] [Related]
11. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic corticosteroids injections: a systematic review of literature.
Lavigne P; Lavigne F; Saliba I
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2271-8. PubMed ID: 26100030
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic gentamicin for Ménière's disease.
Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
[TBL] [Abstract][Full Text] [Related]
14. Intratympanic Treatment in Menière's Disease, Efficacy of Aminoglycosides Versus Corticosteroids in Comparison Studies: A Systematic Review.
Yaz F; Ziylan F; Smeeing DPJ; Thomeer HGXM
Otol Neurotol; 2020 Jan; 41(1):1-10. PubMed ID: 31789967
[TBL] [Abstract][Full Text] [Related]
15. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Ménière's disease.
She W; Lv L; Du X; Li H; Dai Y; Lu L; Ma X; Chen F
J Laryngol Otol; 2015 Mar; 129(3):232-7. PubMed ID: 25655232
[TBL] [Abstract][Full Text] [Related]
17. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
18. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing].
Wang XY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):942-944. PubMed ID: 29771059
[No Abstract] [Full Text] [Related]
19. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
